Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ELMOD2 Inhibitors

ELMOD2 inhibitors belong to a class of chemical compounds specifically designed to target and modulate the activity of the ELMOD2 protein. ELMOD2, short for Engulfment and Cell Motility 2, is a protein encoded by the ELMOD2 gene and is primarily involved in cellular processes related to membrane trafficking and cytoskeleton dynamics. The role of ELMOD2 in regulating these essential cellular functions makes it an attractive target for research and development in various fields. ELMOD2 inhibitors are engineered to interfere with the function of this protein, either by inhibiting its activity or altering its interactions with other cellular components. The ELMOD2 protein plays a crucial role in vesicle trafficking, a process that enables the movement of molecules and cellular components within cells. It is particularly important in maintaining the integrity of cell membranes and facilitating the transport of cargo between different cellular compartments. ELMOD2 inhibitors are designed to disrupt these processes by specifically binding to the ELMOD2 protein, thus preventing it from fulfilling its normal functions. This disruption can have a profound impact on cellular homeostasis and can be harnessed for various research purposes. By studying the effects of ELMOD2 inhibition, scientists aim to gain insights into the underlying mechanisms of cellular processes and identify novel targets for intervention in the future.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Imatinib inhibits the BCR-ABL tyrosine kinase, blocking cell signaling in chronic myeloid leukemia.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib targets multiple kinases, including Raf and VEGFR, to inhibit angiogenesis and tumor cell proliferation.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$240.00
$1030.00
7
(1)

MDV3100 antagonizes the androgen receptor for prostate cancer by blocking androgen-driven cell growth.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$85.00
$132.00
$287.00
$495.00
$3752.00
42
(0)

Erlotinib inhibits the EGFR kinase, disrupting cell signaling pathways involved in the growth of lung cancer cells.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib is a proteasome inhibitor used in multiple myeloma therapy, disrupting protein degradation and cell survival.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

Olaparib is a PARP inhibitor, disrupting DNA repair mechanisms in cancer cells, particularly in BRCA-mutated tumors.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$115.00
$415.00
11
(1)

Vemurafenib targets mutated BRAF proteins in melanoma, blocking aberrant signaling pathways driving cancer cell growth.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Lapatinib inhibits EGFR and HER2 kinases, used for HER2-positive breast cancer by disrupting receptor-mediated cell growth.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Sunitinib targets multiple receptor tyrosine kinases, inhibiting angiogenesis and tumor cell growth in various cancers.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib inhibits BCR-ABL and Src kinases, used for chronic myeloid leukemia and Philadelphia chromosome-positive ALL.